MedPath

the comparison of ECG changes propofole and sevoflurane cochlear implantatio

Phase 2
Conditions
cochlear implantation.
other specified diseases of inner ear(h83.8(
DISEASES O
Registration Number
IRCT2017082131487N2
Lead Sponsor
iran university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
64
Inclusion Criteria

inclusion critria : patients aged 6 months to 18years condidate for cochlear implantation . exclusion critria: known case of jervell lange nielson syndrome , patients with any cardiac disease, ECG abnormalitie, electrolyte abnormalitie, usage of drags which prolong the QT interval and family history of QT prolongation .

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
QT INTERVAL. Timepoint: AFTER THE INDACTION. Method of measurement: ECG MONITORING AND CALCULATED BY THE CARDIOLOGIST.
Secondary Outcome Measures
NameTimeMethod
PROLONGET TP-E INTERVALL. Timepoint: 5 AND 15 MINIUTE AFTER DRAG ADMINISRATION. Method of measurement: ECG MONITORING AND CALCULATED BY CARDIOLOGIST.
© Copyright 2025. All Rights Reserved by MedPath